Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
SPRB
SPRB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SPRB News
Harbour BioMed Exercises Warrant to Acquire 3.8% of Spruce Biosciences Inc.
Jan 21 2026
Benzinga
Harbour BioMed Acquires 3.8% Stake in Spruce Biosciences (SPRB)
Jan 19 2026
NASDAQ.COM
Harbour BioMed Acquires 3.8% Stake in Spruce Biosciences
Jan 19 2026
PRnewswire
Harbour BioMed Acquires 3.8% of Spruce Biosciences, Enhancing Strategic Partnership
Jan 19 2026
Newsfilter
Spruce Biosciences Secures $15 Million Loan to Support MPS IIIB Treatment Development
Jan 08 2026
Newsfilter
Cellectis SA Receives Buy Rating with $9 Price Target from Clear Street
Dec 23 2025
Benzinga
Spruce Biosciences Appoints Keli Walbert to Board, Aiming for TA-ERT Launch
Dec 15 2025
Newsfilter
Spruce Biosciences (SPRB) Price Target Raised by 55.76% to 213.69
Dec 06 2025
NASDAQ.COM
Post-Market Highlights: Jasper, NRx, Unicycive, Spruce, Evaxion, Solana, and Protara See Gains After Trading Hours
Dec 02 2025
NASDAQ.COM
Spruce Biosciences Shares Surge 2,900% Following FDA Breakthrough Therapy Designation Sparks Investor Excitement
Oct 09 2025
TipRanks
Tuesday's Major Stock Market Highlights: Morning News Summary!
Oct 07 2025
TipRanks
Spruce Biosciences Shares Surge 2,900% Following FDA Fast Track Approval, Sparking Investor Excitement
Oct 07 2025
TipRanks
What Caused Spruce Biosciences Stock (SPRB) to Surge More than 1,300% in an Impressive Rally?
Oct 07 2025
TipRanks
Spruce Bio Soars Following Breakthrough Therapy Designation for Enzyme Replacement Treatment
Oct 06 2025
SeekingAlpha
Spruce Biosciences Restarts Nasdaq Trading with Shares Rising More Than 40%
Sep 15 2025
SeekingAlpha
Upcoming Stock Splits This Week (August 4 to August 8) – Stay Invested
Aug 04 2025
TipRanks
Show More News
